About northwest on their site.. http://m.nwbio.com....impressive tech though the whole personalised approach means very expensive...moditope and immunobody on the other hand are off the shelf and data wise could well match what undeniably seems to be very impressive data coming from their trials
Morning , we seem to be witnessing quite a shift in the risk versus benefit arena, mainly due to the big advances scientists are making in the understanding of physiological machanisms !! Blimey, that was a mouthful eh !! Take care!
RE: Morning Chelsea
Have wondered whats happened to him, Faraday and all. Looking round the BBs though our sector is going through a very strange time.
It wouldn't surprise me if Navid Malik from cenkos is involved in the chain somewhere .. He was at the investor day , been to parliament , talks to Pharma , does seminars on regenerative medicine / immunotherapy including the fund raising side ... - he thinks this market is at the start of a ten year bull run .... Etc .... Just my thoughts as ever..
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.